Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Region Hovedstadens forskningsportal Forside
Hjælp og OSS
Dansk
English
Forside
Hospitaler/afdelinger
Forskere
Publikationer
Aktiviteter
Priser
Søg efter ekspertise, navn eller tilknytning
SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL
CVD-REAL Investigators and Study Group
Steno Diabetes Center Copenhagen
113
Citationer (Scopus)
Oversigt
Fingeraftryk
Fingeraftryk
Dyk ned i forskningsemnerne om 'SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL'. Sammen danner de et unikt fingeraftryk.
Sorter
Vægt
Alfabetisk
Keyphrases
Cardiovascular Disease
100%
Cardiovascular Risk
100%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
100%
Hazard Ratio
58%
Heart Failure
58%
Confidence Interval
50%
Established Cardiovascular Disease
33%
Low Risk
25%
Risk of Death
25%
Cardiovascular Outcomes
16%
Glucose-lowering Drugs
16%
Failure Hazard
16%
New User
16%
Comparative Effectiveness
16%
Death Rate
8%
Type 2 Diabetes Mellitus (T2DM)
8%
Low Dose Rate
8%
Mortality Hazard
8%
Therapy Failure
8%
Subclinical Cardiovascular Disease
8%
Ongoing Clinical Trials
8%
Propensity Score
8%
Propensity Score Matching
8%
Inhibitor Study
8%
Drug Use Initiation
8%
Medicine and Dentistry
Cardiovascular Risk
100%
Cardiovascular Disease
100%
Sodium Glucose Cotransporter 2 Inhibitor
81%
Hazard Ratio
63%
Heart Failure
63%
Heart Death
27%
Cardiovascular System
18%
Observational Study
18%
Maturity Onset Diabetes of the Young
9%
Clinical Trial
9%
Propensity Score Matching
9%
Pharmacology, Toxicology and Pharmaceutical Science
Cardiovascular Disease
100%
Cardiovascular Risk
100%
Sodium Glucose Cotransporter 2 Inhibitor
81%
Heart Failure
63%
Heart Death
27%
Observational Study
18%
Non Insulin Dependent Diabetes Mellitus
9%
Clinical Trial
9%
Biochemistry, Genetics and Molecular Biology
Cotransporter
100%
Observational Study
22%
Clinical Trial
11%